Anthony Bergmann

Anthony Bergmann

Director of Finance/CFO bei CAPRICOR THERAPEUTICS, INC.

Vermögen: 16 167 $ am 31.03.2024

38 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Anthony Bergmann

EinheitArt der EinheitIndustrie
USC Marshall School of Business
51
College/University Other Consumer Services 51
Providence College
48
College/University Other Consumer Services 48
Public Company Pharmaceuticals: Major 32
11
Subsidiary Biotechnology 11

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Anthony Bergmann

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Daron Evans

Darlene P. Horton

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

MORGAN STANLEY Investment Managers

Brooks Hansen

Giuseppe Guerriero

Private Equity Analyst

President

Miscellaneous Commercial Services

Casey Chory

Anthony Di Leva

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Pedro Granadillo

Joshua Kazam

Peter Morgan Kash

Paul Anthony Mieyal

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

College/University

Karen Krasney

Trent Ketterer

Kyle Wiest

Evan Slavik

Graduate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

University of California, Los Angeles College/University

Frank Litvack

Houman D. Hemmati

Karen Krasney

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Biotechnology

Joshua Kazam

Peter Morgan Kash

Paul Anthony Mieyal

Director/Board Member

Director/Board Member

Director/Board Member

Investment Managers

Joshua Kazam

Arie Belldegrun

Kate Bechtold

Founder

Founder

Private Equity Investor

The Trustees of Columbia University in The City of New York College/University

Leland Gershell

Brooks Hansen

Paul Auwaerter

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Investment Managers

Joshua Kazam

Arie Belldegrun

Peter Morgan Kash

Founder

Chairman

Private Equity Investor

Bryant University College/University

Mark Abate

Gianni Del Signore

Benjamin Zampello

Graduate Degree

Masters Business Admin

Graduate Degree

The Johns Hopkins University College/University

Linda Marbán

Rachel Smith

Paul Auwaerter

Corporate Officer/Principal

Doctorate Degree

Masters Business Admin

ARNO THERAPEUTICS, INC. Pharmaceuticals: Major

Joshua Kazam

Arie Belldegrun

Peter Morgan Kash

Founder

Chairman

Founder

State of Massachusetts Province/State

Matthew P. O'Connor

Lauren Jones

Corporate Officer/Principal

Corporate Officer/Principal

The Johns Hopkins University School of Medicine College/University

Kristi Elliott

Paul Auwaerter

Doctorate Degree

Corporate Officer/Principal

Financial Conglomerates

Joshua Kazam

Arie Belldegrun

Director/Board Member

Director/Board Member

Biotechnology

Joshua Kazam

Arie Belldegrun

Founder

Founder

Real Estate Investment Trusts

Joshua Kazam

Arie Belldegrun

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Patrick Smerkers

Breanna McKeehan

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Rory J. Davan

Scott Lawrence Palumbo

Masters Business Admin

Masters Business Admin

Medical Specialties

David Musket

Frank Litvack

Director/Board Member

Chief Executive Officer

UROGEN PHARMA LTD. Biotechnology

Arie Belldegrun

Kate Bechtold

Chairman

Director/Board Member

Suffolk University College/University

Eric R. Cunnane

Matthew P. O'Connor

Graduate Degree

Graduate Degree

Investment Managers

Benjamin Zampello

Jessica Iannetta

Director/Board Member

Director/Board Member

Yale University College/University

Earl Collier

W. Martucci

Undergraduate Degree

Doctorate Degree

Investment Managers

Adrian Wirt

Warren Michael Sypinero

Analyst-Fixed Income

Corporate Officer/Principal

Electronic Equipment/Instruments

Frank Litvack

Karimah Es Sabar

Chairman

Director/Board Member

Miscellaneous Commercial Services

Frank Litvack

Karen Krasney

Director/Board Member

Director/Board Member

Financial Conglomerates

David Musket

Teddy Fusaro

Corporate Officer/Principal

Analyst-Equity

NEPHROS, INC. Medical Specialties

Daron Evans

Paul Anthony Mieyal

Chief Executive Officer

Chief Executive Officer

Investment Banks/Brokers

Bob Doctor

Adrian Wirt

Analyst-Equity

Market Strategist

Investment Banks/Brokers

Matt B. Cioppa

Kai Wang

Analyst-Equity

Analyst-Equity

Investment Managers

Joshua Kazam

Arie Belldegrun

Director/Board Member

Chairman

Orion Biomedical Fund LP

Joshua Kazam

Peter Morgan Kash

Chief Investment Officer

Corporate Officer/Principal

Investment Managers

Joshua Kazam

Peter Morgan Kash

Corporate Officer/Principal

Corporate Officer/Principal

KRONOS BIO, INC. Pharmaceuticals: Major

Joshua Kazam

Arie Belldegrun

Founder

Founder

ALLOGENE THERAPEUTICS, INC. Biotechnology

Joshua Kazam

Arie Belldegrun

Founder

Founder

College/University

Paul Anthony Mieyal

Linda Marbán

Undergraduate Degree

Doctorate Degree

Rutgers State University of New Jersey College/University

Anatoly Kvitnitsky

Kristi Elliott

Undergraduate Degree

Graduate Degree

UCLA Anderson School of Management College/University

Gregory W. Schafer

Trent Ketterer

Masters Business Admin

Masters Business Admin

University of Pennsylvania College/University

Gregory W. Schafer

Peter Morgan Kash

Undergraduate Degree

Corporate Officer/Principal

Investment Banks/Brokers

Joshua Kazam

Peter Morgan Kash

Director/Board Member

Chairman

Statistik

International

Vereinigte Staaten 44
Kanada 2
Vereinigtes Königreich 2
Israel 2

Sektoral

Finance 15
Health Technology 14
Consumer Services 14
Commercial Services 4
Government 2

Operativ

Director/Board Member 202
Corporate Officer/Principal 111
Undergraduate Degree 94
Private Equity Investor 46
Founder 44
  1. Börse
  2. Insiders
  3. Anthony Bergmann
  4. Unternehmensverbindungen